Author

Kalai Mangai Muthukumarasamy

Montreal Heart InstituteORCID 0000-0001-7908-8364Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:electrophysiology· 1 Assay:imaging· 1 Organism:mouse· 1

Frequent Co-Authors

Amrish DeshmukhiD· 1 shared André Monteiro da RochaiD· 1 shared Anna NozzaiD· 1 shared Dobromir DobreviD· 1 shared Donald M. BersiD· 1 shared Feng XiongiD· 1 shared Florian Bruns· 1 shared Hakan OraliD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Amrish DeshmukhORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringbioRxivPreprintMay 23, 2025

Modeling Atrial Fibrillation through Intermittent Tachypacing-Induced Remodeling in hiPSC-Derived Atrial Cardiomyocytes and Atrial Fibroblast

Paul Kozlowski, Kalai Mangai Muthukumarasamy, Amrish Deshmukh…·Hakan Oral

This study uses hiPSC-derived atrial cardiomyocytes and fibroblasts to model atrial fibrillation through intermittent tachypacing, showing increased AP frequency and fibrosis markers.

DOI 10.1101/2025.05.23.655123

humanelectrophysiology

𝕏 PostBluesky

PathologybioRxivPreprintJan 29, 2025

Time-dependent Mitochondrial Remodeling in Experimental Atrial Fibrillation and Potential Therapeutic Relevance

Xiaoyan Qi, Feng Xiong, Jiening Xiao…·Stanley Nattel

This study examines mitochondrial changes during atrial fibrillation in animals and humans, showing early hyperfunction and damage, and demonstrates that mitochondrial-targeted therapy can prevent adverse remodeling and AF sustainability.

1 citation

humanmouse

𝕏 PostBluesky